融科控股(02323.HK):已就風險顧問檢討作出補救措施
融科控股(02323.HK)公布,董事會今年5月成立獨立調查委員會,就風險管理進行檢討,而公司委聘的顧問羅馬風險諮詢公司,亦已完成第一階段檢討工作,預期第二階段將於9月底完成。
羅馬諮詢識別的問題包括,應收款項虧損撥備管理依據並不充份、部分財務紀錄缺失、審核證明文件不全面等。
公司已採取若干補救措施,應對有關內部控制的問題,羅馬諮詢在第一階段檢討中注意到的缺陷,正在第二階段檢討中進行審閱及評估。
公司董事會及審核委員會確認及同意羅馬識別出的缺陷,並相信羅馬諮詢建議的措施充份,當有關措施全面實施後,足以解決有關缺陷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.